Amgen (AMGN) Convertible Debt (2009 - 2010)
Amgen (AMGN) reported Convertible Debt of $2.2 billion for Q1 2010, down 51.2% from the prior quarter.
Analysis
Amgen (AMGN) Convertible Debt (2009 - 2010) Analysis & Trends
At the end of FY2009, Amgen posted Convertible Debt of $4.51 billion.
- Per Business Quant data, the three quarters before Q1 2010 came in at $4.51 billion (Q4 2009), $4.45 billion (Q3 2009) and $4.38 billion (Q2 2009).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2010 | 2.20 Bn |
| Dec 31, 2009 | 4.51 Bn |
| Sep 30, 2009 | 4.45 Bn |
| Jun 30, 2009 | 4.38 Bn |
API Access
Amgen Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();